|
(Health-NewsWire.Net, May 10, 2015 ) According to the Society for Women’s Health Research in the US, issues specific to the human female anatomy are defined as women’s health. The biological mechanisms influence the clinical course of diseases and disorders differently in women when compared to men. Some of the main women’s health disorders include infertility, menopause, endometriosis and polycystic ovarian syndrome as well as urological disorders and cancers such as breast cancer, cervical cancer, endometrial cancer, and ovarian cancer. In addition, contraception plays an important role in women’s health for many reasons, so this too is also categorized under women’s health.
TechNavio’s analysts forecast the Global Women’s Health market will grow at a CAGR of 3.52 percent over the period 2013-2018.
Complete report on “Global Women’s Health Market 2014-2018” is available http://www.rnrmarketresearch.com/global-womens-health-market-2014-2018-market-report.html . (This is a premium report price at US$2500 for a single user PDF license)
This report covers the present scenario and the growth prospects of the Global Women’s Health market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of various products used for the wellbeing of women, which are listed below based on their application segment:
• Postmenopausal Osteoporosis (Drugs)
• Hormonal Contraceptives (Drugs and Devices)
• Menopause (Drugs)
• Infertility (Drugs)
• Endometriosis (Drugs)
• Polycystic Ovary Syndrome (Drugs)
Inquire for discount on this report at http://www.rnrmarketresearch.com/contacts/discount?rname=195603 .
TechNavio’s report, the Global Women’s Health Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA, and the APAC regions; it also covers the Global Women’s Health market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Actavis plc
• Bayer AG
• Eli Lilly and Co.
• Merck & Co.
• Pfizer Inc.
Other Prominent Vendors
• AbbVie Inc.
• Adamis Pharmaceuticals Corp.
• Agile Therapeutics Inc.
• Amgen Inc.
• ANI Pharmaceuticals Inc.
• Apothecus Pharmaceutical Corp.
• AstraZeneca plc
• Blairex Laboratories Inc.
• Catalysis SL
• Crinetics Pharmaceuticals Inc.
• Dexa Medica Group
• EffRx Inc.
More reports on Women’s Health therapeutics :
Gynecology Deals and Alliances of 2014
The Gynecology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.
Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.
The initial chapters of this report provide an orientation of 2014′s dealmaking and business activities.
Complete report is available at http://www.rnrmarketresearch.com/gynecology-deals-and-alliances-of-2013-market-report.html .
RnR Market Research
Ritesh Tiwari
+ 1-888-391-5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
|
